Hepatic resection is the optimal treatment for patients with hepatocellular carcinoma (HCC) in the very early or early stage [Barcelona Clinic Liver Cancer (BCLC)0/A]. However, recurrence within 2 years occurs in 30%–50% of patients; hence, HCC is the major cause of mortality. This study aimed to develop and validate a clinical model to predict the early recurrence of HCC after curative resection. The proposed nomogram provided better discrimination than the BCLC stage and AJCC-TNM (eight edition).
This abstract and the presentation materials are available to members only; a login is required.